In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 49 for your search:
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  graft versus host disease
Trial Type:  Supportive care
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 1 to 29
Sponsor: NCI, Other
Protocol IDs: ASCT0031, COG-ASCT0031, CCG-S9701, NCI-P02-0213, NCT00031824

2.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-01149, ENTERON-00-02, NCI-G02-2098, RPCI-DS-01-09, NCT00043147

3.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 1 to under 22 at first relapse
Sponsor: NCI, Other
Protocol IDs: ASCT0431, NCI-2009-01068, CDR0000500131, COG-PBMTC-ONCO51, COG-ASCT0431, U10CA098543, NCT00382109

4.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 2 to 55
Sponsor: NCI, Other
Protocol IDs: 385, U01HL069294, BMT CTN 0402, U01 HL069294-05, NCT00406393

5.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000269672, DFCI-99279, RPCI-DS-0218, ROCHE-RPCI-DS-0218, NCT00053976

6.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 669, U01HL069294, BMT CTN 0802, U01 HL069294-06, NCT01002742

7.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2327.00, NCI-2010-00323, P01CA018029, NCT00929695

8.

Phase: Phase II, Phase I
Type: Supportive care
Status: Closed
Age: Not specified
Sponsor: NCI
Protocol IDs: UCLA-9701029, NCI-G99-1650, NCT00004194

9.

Phase: Phase II, Phase I
Type: Supportive care
Status: Closed
Age: 5 to 50
Sponsor: NCI
Protocol IDs: FHCRC-126.8, NCI-T91-0013D, T91-0013

10.

Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 5 to 75
Sponsor: NCI, Other
Protocol IDs: 1500.00, FHCRC-1500.00, RPCI-DS-99-27, NCI-H01-0067, CDR0000068475, NCT00010283

11.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 65 and under
Sponsor: NCI, Other
Protocol IDs: 1723.00, FHCRC-1723.00, CDR0000270397, NCT00054340

12.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1668.00, NCI-2012-00668, P30CA015704, P01CA018029, FHCRC-1668.00, NCT00078858

13.

Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: Per primary treatment protocol
Sponsor: NCI, Other
Protocol IDs: 1811.00, FHCRC-1811.00, CDR0000378004, NCT00089037

14.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 12 to 50
Sponsor: NCI
Protocol IDs: MDA-DM-93120, NCI-G96-1007

15.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 5 to 65
Sponsor: NCI
Protocol IDs: RPCI-DS-96-67, NCI-G97-1247

16.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: specified in BMT protocols
Sponsor: NCI
Protocol IDs: EUC-14786, NCI-T86-0136O, T86-0136

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000341678, U10CA031946, CALGB-100101, ECOG-1010, NCT00074035

18.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 18 to 55
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0303036, OSIRIS-240, NCT00081055

19.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: 1898.00, NCI-2010-00267, P01CA078902, P30CA015704, FHCRC-1898.00, 5788, NCT00089011

20.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1938.00, NCI-2010-00268, P30CA015704, P01CA018029, FHCRC-1938.00, 5887, NCT00105001

21.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CASE1Z04, P30CA043703, CASE-CWRU-1Z04, CWRU-060419, NCT00109993

22.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 10 and over
Sponsor: NCI, NHLBI
Protocol IDs: 285, BMT CTN 0302, U01 HL069294-05, JHOC-05040403, JHOC-J0519, NCT00224874

23.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 01089, P30CA033572, CHNMC-01089, CDR0000566376, NCT00544115

24.

Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 2 and over
Sponsor: NCI, Other
Protocol IDs: 06141, P30CA033572, CHNMC-06141, CDR0000579340, NCT00589563

25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 4 and over
Sponsor: NCI
Protocol IDs: 080148, 08-C-0148, NCI-08-C-0148, NCI-P07301, 8196, NCT00702689
1   
New Search